Europe Bronchodilators Market Size & Outlook, 2022-2030

The bronchodilators market in Europe is expected to reach a projected revenue of US$ 6,818.5 million by 2030. A compound annual growth rate of 3% is expected of Europe bronchodilators market from 2023 to 2030.
Revenue, 2022 (US$M)
$5,393.7
Forecast, 2030 (US$M)
$6,818.5
CAGR, 2023 - 2030
3%
Report Coverage
Europe

Europe bronchodilators market highlights

  • The Europe bronchodilators market generated a revenue of USD 5,393.7 million in 2022.
  • The market is expected to grow at a CAGR of 3% from 2023 to 2030.
  • In terms of segment, beta-adrenergic bronchodilators was the largest revenue generating drug class in 2022.
  • Beta-Adrenergic Bronchodilators is the most lucrative drug class segment registering the fastest growth during the forecast period.
  • Country-wise, France is expected to register the highest CAGR from 2023 to 2030.


Europe data book summary

Market revenue in 2022USD 5,393.7 million
Market revenue in 2030USD 6,818.5 million
Growth rate3% (CAGR from 2022 to 2030)
Largest segmentBeta-adrenergic bronchodilators
Fastest growing segmentBeta-Adrenergic Bronchodilators
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBeta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives
Key market players worldwideGSK PLC, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Mylan, Merck KGaA, Merck & Co Inc, Novartis AG ADR, Boehringer Ingelheim, Sun Pharmaceutical Industries, Glenmark Pharmaceuticals


Other key industry trends

  • In terms of revenue, Europe region accounted for 24.3% of the global bronchodilators market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 6,575.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Bronchodilators Market Companies

Name Profile # Employees HQ Website

Europe bronchodilators market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchodilators market will help companies and investors design strategic landscapes.


Beta-adrenergic bronchodilators was the largest segment with a revenue share of 41.15% in 2022. Horizon Databook has segmented the Europe bronchodilators market based on beta-adrenergic bronchodilators, anticholinergic bronchodilators, xanthine derivatives covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe bronchodilators market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe bronchodilators market databook

  • Our clientele includes a mix of bronchodilators market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe bronchodilators market, including forecasts for subscribers. This continent databook contains high-level insights into Europe bronchodilators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe bronchodilators market report size, by country, 2018-2030 (US$M)

Europe Bronchodilators Market Share, 2022 & 2030 (US$M)

Europe bronchodilators market report size, by country, 2018-2030 (US$M)

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more